INSULET CORP (PODD) Stock Price, Quote, News and Overview
NASDAQ:PODD - Nasdaq - US45784P1012 - Common Stock - Currency: USD
PODD Quote, Performance and Key Statistics
252.29
+1.02 (+0.41%)
The current stock price of PODD is 252.29 USD. In the past month the price decreased by -4.14%. In the past year, price increased by 44.64%.
PODD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.35 | 226.76B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.51 | 184.80B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.1 | 152.15B | ||
| SYK | STRYKER CORP | 30.67 | 142.72B | ||
| MDT | MEDTRONIC PLC | 15.87 | 108.71B | ||
| BDX | BECTON DICKINSON AND CO | 14.89 | 59.46B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.03 | 44.38B | ||
| IDXX | IDEXX LABORATORIES INC | 38.46 | 35.06B | ||
| RMD | RESMED INC | 26.06 | 34.75B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.66 | 32.20B | ||
| DXCM | DEXCOM INC | 43.26 | 27.99B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.04 | 23.83B |
Related stock screener links
About PODD
Company Profile
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts and currently employs 3,900 full-time employees. The company went IPO on 2007-05-15. The company is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. The company also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.
Company Info
INSULET CORP
100 Nagog Park
Acton MASSACHUSETTS 01720 US
CEO: Shacey Petrovic
Employees: 3000
Company Website: https://www.omnipod.com
Investor Relations: https://investor.insulet.com
Phone: 19786007000
INSULET CORP / PODD FAQ
What is the stock price of INSULET CORP today?
The current stock price of PODD is 252.29 USD. The price increased by 0.41% in the last trading session.
What is the ticker symbol for INSULET CORP stock?
The exchange symbol of INSULET CORP is PODD and it is listed on the Nasdaq exchange.
On which exchange is PODD stock listed?
PODD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for INSULET CORP stock?
31 analysts have analysed PODD and the average price target is 322.28 USD. This implies a price increase of 27.74% is expected in the next year compared to the current price of 252.29. Check the INSULET CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is INSULET CORP worth?
INSULET CORP (PODD) has a market capitalization of 17.72B USD. This makes PODD a Large Cap stock.
How many employees does INSULET CORP have?
INSULET CORP (PODD) currently has 3000 employees.
What are the support and resistance levels for INSULET CORP (PODD) stock?
INSULET CORP (PODD) has a support level at 245.25 and a resistance level at 252.68. Check the full technical report for a detailed analysis of PODD support and resistance levels.
Is INSULET CORP (PODD) expected to grow?
The Revenue of INSULET CORP (PODD) is expected to grow by 19.07% in the next year. Check the estimates tab for more information on the PODD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INSULET CORP (PODD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PODD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PODD, evaluating the profitability, health, valuation and growth aspects
- INSULET CORP (PODD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INSULET CORP (PODD) Sales and EPS estimates to see what analysts future expectations are.
- INSULET CORP (PODD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INSULET CORP (PODD) Insider and Institutional Ownership to learn about the owners and their transactions.
- INSULET CORP (PODD) Stock Chart to make your own analysis
- INSULET CORP (PODD) Latest news and press-releases to stay up to date.
Does INSULET CORP (PODD) stock pay dividends?
PODD does not pay a dividend.
When does INSULET CORP (PODD) report earnings?
INSULET CORP (PODD) will report earnings on 2025-05-08, after the market close.
What is the Price/Earnings (PE) ratio of INSULET CORP (PODD)?
The PE ratio for INSULET CORP (PODD) is 75.76. This is based on the reported non-GAAP earnings per share of 3.33 and the current share price of 252.29 USD. Check the full fundamental report for a full analysis of the valuation metrics for PODD.
What is the Short Interest ratio of INSULET CORP (PODD) stock?
The outstanding short interest for INSULET CORP (PODD) is 3.37% of its float. Check the ownership tab for more information on the PODD short interest.
PODD Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to PODD. When comparing the yearly performance of all stocks, PODD is one of the better performing stocks in the market, outperforming 90.3% of all stocks.
PODD Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to PODD. PODD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
PODD Financial Highlights
Over the last trailing twelve months PODD reported a non-GAAP Earnings per Share(EPS) of 3.33. The EPS increased by 22.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.19% | ||
| ROA | 13.55% | ||
| ROE | 34.52% | ||
| Debt/Equity | 1.08 |
PODD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to PODD. The Buy consensus is the average rating of analysts ratings from 31 analysts.
For the next year, analysts expect an EPS growth of 29.11% and a revenue growth 19.07% for PODD